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Objective. The aim of the present study was to evaluate the possible antioxidant eﬀects of nanoconjugated vancomycin against
VRSA infection on select makers of oxidative damage and antioxidant status in spleen. Methods. A coagulase-positive VRSA strain
was used for this study. VRSA infection was developed in Swiss mice by intraperitoneal injection of 5 × 106 CFU/mL bacterial
solutions. VRSA-infected mice were treated with nanoconjugated vancomycin at its eﬀective dose for 10 days. After decapitation,
blood was used for determination of viable bacteria count and spleen was excised from control and experimental groups,
homogenized and used for diﬀerent biochemical estimations. Results. Nitrate level, myeloperoxidase activity, lipid peroxidation,
protein oxidation, oxidized glutathione, and DNA fragmentation level were increased signiﬁcantly (P<0.05) in spleen of VRSA-
infected group as compared to control group, and reduced glutathione level, activity of SOD, CAT, GPx, GR, and GST were
decreased signiﬁcantly (P<0.05); which were increased or decreased signiﬁcantly (P<0.05) near to normal in nanoconjugated
vancomycin-treated group. Conclusion. These ﬁndings suggest the potential use and beneﬁcial role of nanoconjugated vancomycin
against VRSA-infection-induced oxidative stress and DNA damage in spleen.
1.Introduction
Staphylococcus aureus is facultatively anaerobic, Gram-
positive coccus and is the most common cause of staph
infections. It is frequently part of the skin ﬂora found in the
nose and on skin. About 20% of the human populations are
long-term carriers of S. aureus [1]. S. aureus has developed
resistance to most classes of antimicrobial agents. Penicillin
was the ﬁrst choice of antibiotics to treat staphylococcal
infection. In 1944, by destroying the penicillin by penicilli-
nase, S. aureus became resistant [2]. More than 90% of S.
aureus strains are resistant to penicillin [3]. Methicillin, a
semisyntheticpenicillin,wasusedtotreatpenicillin-resistant
Staphylococcus aureus but resistance ﬁnally emerged in 1962
[4, 5]. Vancomycin, a glycopeptide antibiotic, continues
to be an important antimicrobial agent to treat MRSA
but resistance ﬁnally emerges. In June 2002, the world’s
ﬁrst reported clinical infection due to S. aureus with high
resistance to vancomycin (VRSA) was diagnosed in a patient
intheUSA[6].Recently,wehaveisolatedthirtypathogenicS.
aureus from post-operative pus sample; out of them twenty-
two were vancomycin sensitive and rests were vancomycin
resistant [7].
S. aureus causes chronic or relapsing diseases and is
reportedtopersistasanopportunisticintracellularorganism
both in vitro and in vivo [8]. S. aureus was able to
survive within phagocytic cells both in polymorphonuclear
leukocytes (PMN) and monocytes [9]. In vitro studies
demonstrated that pathogenic strains of S. aureus could
survive for long periods of time inside both PMN and
monocytes isolated from diﬀerent animals and humans. To
induce an infection in host, the pathogens must cope with2 Pathology Research International
their changing environment and have to attack continuously
the host to weaken the immune system [10].
Chitinisthemajorstructuralcomponentofinvertebrates
like crab, shrimp, shells and the cell walls of fungi. Chitosan
(CS), the deacetylated form of chitin, is a linear polysaccha-
ride, composed of glucosamine and N-acetyl glucosamine
linked in a β-linkage [11]. CS has been reported to possess
immunestimulatingpropertiessuchasincreasingaccumula-
tionandactivationofmacrophagesandpolymorphonucleus,
augmenting antibody responses and inducing production
of cytokines [12]. Carboxymethyl chitosan (CMC) is a
linear polysaccharide composed of β (1,4) glycosidic linkages
between 6-carboxymethyl-D-glucosamine monomers. CMC
is synthesized from CS by carboxylation of the hydroxyl and
amine groups [13]. In our previous laboratory report, we
synthesized CMC-EDBE-FA nanoparticle based on carboxy
methyl chitosan tagged with folic acid by covalent linkage
through 2,2 -(ethylenedioxy)bis(ethylamine), vancomycin
was loaded onto it, the complex is called “nanoconjugated
vancomycin,” observed its bactericidal activity against S.
aureus [14]; and reported that CMC-EDBE-FA nanoparticle
is nontoxic [15]. We also reported that in vivo challenge
of VSSA and VRSA for 5 days can produce the highest
degree of damage in lymphocyte through the increased
productionofnitricoxide,andTNF-αthatleadstodecreased
antioxidant status in cell and 10 days of successive treatment
of nanoconjugated vancomycin also eliminate in vivo VSSA
and VRSA infection [16]. In light of these ﬁndings, the
present study was conducted to obtain information on the
possible antioxidant eﬀects of nanoconjugated vancomycin
against VRSA infection on select makers of oxidative damage
and antioxidant status in spleen.
2.MaterialsandMethods
2.1. Chemicals and Reagents. Sodium dodecyl sulfate (SDS),
5 ,5 -dithio(bis)-2-nitrobenzoic acid (DTNB), standard
reduced glutathione (GSH), glutathione reductase (GR),
NADPH, Na4, NADPH, and oxidized glutathione (GSSG)
were purchased from Sigma Chemical Co., USA. Sodium
chloride (Nacl), sodium dodecyl sulfate, sucrose, ethylene
diamine tetra acetate (EDTA), tryptic soy broth, and
mannitolsaltagarwerepurchasedfromHimedia,India.Tris-
Hcl, KH2PO4 and K2HPO4, alcohol, formaldehyde, paraﬃn
wax, xylene, haematoxylin, eosin, DPX, diphenylamine
(DPA), O-phenylenediamine, and other chemicals were
procured from Merck Ltd., SRL Pvt. Ltd., Mumbai, India.
All other chemicals were from Merck Ltd., SRL Pvt., Ltd.,
Mumbai and were of the highest grade available.
2.2. Animals. Experiments were performed using twenty-
four (24) Swiss male mice, 6–8 weeks old, weighing 20–25g.
The animals were fed standard pellet diet and were given
water ad libitum a n dh o u s e di np o l y p r o p y l e n ec a g e( T a r s o n )
in the departmental animal house with 12h light:dark cycle
and the temperature of 25 ± 2◦C. The animals were allowed
to acclimatize for one week. The animals used did not
show any sign of malignancy or other pathological processes.
Animals were maintained in accordance with the guidelines
of the National Institute of Nutrition, Indian Council of
Medical Research, Hyderabad, India, and approved by the
ethical committee of Vidyasagar University.
2.3. Bacterial Strain. We used a coagulase-positive vanco-
mycin-resistant Staphylococcus aureus (MMC-17) strain that
was isolated from human post-operative pus sample and
was grown at 37◦C for overnight in tryptic soy broth [7].
The bacterial culture was centrifuged at 15,000rpm for 15
minutes. The pellet was resuspended and washed with sterile
phosphate buﬀer saline (PBS). Using a UV spectropho-
tometer (Shimadzu, USA) at an absorbance of 620nm, we
adjustedtheviablebacterialcounttoapproximately1.0×109
colony-forming units (CFU)/mL, which corresponded to an
optical density of 1.6. The bacterial suspension was adjusted
by serial dilution in PBS to give a ﬁnal concentration of
approximately 5×106 in 100μL of bacterial suspension [17].
2.4. Preparation of CMC-EDBE-FA Nanoparticle and Loading
of Vancomycin. CMC-EDBE-FA nanoparticle was prepared
and vancomycin was loaded onto it according to our
previous laboratory report [14].
2.5. Development of VRSA Infection in Swiss Mice. VRSA
infection was developed in male Swiss mice by intraperi-
toneal (i.p.) injection of 100μL of bacterial suspension
containing 5×106 CFU/mL according to our previous lab-
oratory report [16].
2.6. Experimental Design. VRSA-infected mice were treated
with nanoconjugated vancomycin for successive 10 days
at a dose of 500mg/kgbw/day. The dose and duration of
nanoconjugated vancomycin was selected from our previous
laboratory report [16]. The following groups were consid-
ered for the experiment: Group I: control, Group II: VRSA
infection, Group III: VRSA infection+500mg/kgbw/day
nanoconjugated vancomycin. After the termination of the
experiment, animals were sacriﬁced by an intraperitoneal
injection of sodium pentobarbital (60–70mg/kg body
weight) [18]a n db l o o d( n = 6/group) was used for the
determination of viable bacteria count.
2.7. Separation and Homogenization of Spleen. After decap-
itation, spleen was excised from experimental mice of
diﬀerent experimental groups and washed with cold normal
saline. Washed tissues of two mice from each group were
perfused with normal saline and formalin for histological
study and the rest washed tissues of six mice were immedi-
ately homogenized in the ice-cold buﬀer containing 0.25M
sucrose, 1mM EDTA, and 1mM Tris-Hcl, pH 7.4. The
homogenate was ﬁrst centrifuged at 600 ×gf o r1 0 m i n
at 4◦C, and the supernatant was stored at −80◦C for the
biochemical estimation of diﬀerent parameters.
2.8. Histopathological Evaluation. Histological analysis of
spleen of each experimental group was performed by the
method of Iranloye and Bolarinwa [19]. The tissues that
were perfused in saline and formalin were ﬁxed for 7 daysPathology Research International 3
in 10% formaldehyde after which dehydration was carried
out in ascending grade of alcohol. The tissues were then
cleared of xylene overnight (16 hours) to remove the
alcohol. Inﬁltration/impregnation was done in three changes
of molten soft paraﬃn wax at ≤68◦Cf o r1h o u re a c h .
Embedding and casting in paraﬃn wax with wooden block
was done and sectioning of 5μm thick carried out using a
microtome.Thesectionedtissuesofspleenweremountedon
slides using a thin ﬁlm of egg albumen smeared on each side.
T h es e c t i o n sw e r ed e p a r a ﬃnized in xylene, passed through
alcohol, stained with haematoxylin-eosin, and mounted in
neutral DPX medium. The slides were then evaluated for
pathologicalchangesunderOlympusresearchphasecontrast
microscope (Model: CX41; Olympus Singapore Pvt. Ltd.,
Valley Point Oﬃce Tower, Singapore).
2.9. Quantiﬁcation of Viable Bacteria in Blood. 100μLo f
blood was inoculated in 1.0mL sterile tryptic soy broth with
sterile disposable microtips, grown at 37◦C for overnight,
plated onto tryptic soy agar and mannitol salt agar plates in
triplicate, and incubated at 37◦C for 24 hours. Colonies were
counted by dilution platting method and expressed as CFU
per mL.
2.10. Biochemical Estimation
2.10.1. Nitrite (NO) Level. After treatment schedule, 100μL
of Griess reagent (containing 1 part of 1% sulfanilamide in
5% phosphoric acid, and 1 part of 0.1% of N-C-1 naphthyl
ethylene diamine dihydrochloride) was added to 100μLo f
sample, incubated at room temperature for 10 minutes;
readings were taken in a UV spectrophotometer at 550nm
and compared to a sodium nitrite standard curve (values
ranging between 0.5 and 25μM). The levels of NO were
expressed as μM/mg protein [16].
2.10.2. Determination of Myeloperoxidase (MPO) Activity.
200μL of cell lysate was reacted with 200μL substrate (con-
taining H2O2 and OPD) in the dark for 30min. The blank
was prepared with citrate phosphate buﬀer (pH 5.2) and
substrate, in absence of cell-free supernatant. The reaction
was stopped with addition of 100μL 2(N) sulfuric acid, and
reading was taken at 492nm in a spectrophotometer [16].
T h eM P Oa c t i v i t yw a se x p r e s s e di nt e r m so fμM/mg protein.
2.10.3. Determination of Lipid Peroxidation (MDA) Level.
Lipid peroxidation of spleen homogenate was estimated by
the method of KarMahapatra et al., 2009 [20]. Brieﬂy, the
reaction mixture contained Tris-HCl buﬀer (50mM, pH
7.4), tetra-butyl hydroperoxide (BHP) (500μM in ethanol),
and 1mM FeSO4. After incubating the samples at 37◦C
for 90min, the reaction was stopped by adding 0.2mL of
8% sodium dodecyl sulfate (SDS) followed by 1.5mL of
20% acetic acid (pH 3.5). The amount of malondialdehyde
(MDA) formed during incubation was estimated by adding
1.5mL of 0.8% TBA and further heating the mixture at
95◦C for 45min. After cooling, samples were centrifuged,
and the TBA reactive substances (TBARS) were measured
in supernatants at 532nm by using 1.53×105 M−1 cm−1 as
extinction coeﬃcient. The levels of lipid peroxidation were
expressed in terms of nmol/mg protein.
2.10.4. Determination of Protein Carbonyl (PC) Contents.
Protein oxidation was monitored by measuring protein
carbonyl contents by derivatization with 2,4-dinitrophenyl
hydrazine (DNPH) [20]. In general, spleen proteins in
50mM potassium phosphate buﬀer, pH 7.4, were derivatized
with DNPH (21% in 2N HCl). Blank samples were mixed
with 2N HCl incubated at 1h in the dark; protein was
precipitated with 20% trichloroacetic acid (TCA). Under-
ivatized proteins were washed with an ethanol:ethyl acetate
mixture (1:1). Final pellets of protein were dissolved in 6N
guanidine hydrochloride, and absorbance was measured at
370nm. Protein carbonyl content was expressed in terms of
nmol/mg protein.
2.10.5. Determination of Reduced Glutathione (GSH) Level.
Reduced glutathione estimation in spleen homogenate was
performed by the method of KarMahapatra et al., 2009 [20].
The required amount of sample was mixed with 25% of
TCA and centrifuged at 2,000 ×g for 15min to settle the
precipitated proteins. The supernatant was aspirated and
diluted to 1mL with 0.2M sodium phosphate buﬀer (pH
8.0). Later, 2mL of 0.6mM DTNB was added. After 10
minutes the optical density of the yellow-colored complex
formedbythereactionofGSHandDTNB(Ellman’sreagent)
was measured at 405nm. A standard curve was obtained
with standard reduced glutathione. The levels of GSH were
expressed as μg of GSH/mg protein.
2.10.6. Determination of Oxidized Glutathione (GSSG) Level.
The oxidized glutathione level in spleen homogenate was
measured after derivatization of GSH with 2-vinylpyidine
according to the method of KarMahapatra et al., 2009 [20].
In brief, with 0.5mL sample, 2μL of 2-vinylpyidine was
added and incubated for 1hr at 37◦C. Then the mixture was
deprotenized with 4% sulfosalicylic acid and centrifuged at
1,000 ×g for 10min to settle the precipitated proteins. The
supernatantwasaspiratedandGSSGlevelwasestimatedwith
the reaction of DTNB at 412nm in spectrophotometer and
calculated with standard GSSG curve. The levels of GSSG
were expressed as μgo fG S S G / m gp r o t e i n .
2.10.7. Determination of Super Oxide Dismutase (SOD)
Activity. SOD activity of spleen homogenate was deter-
mined from its ability to inhibit the auto-oxidation of
pyrogallol according to KarMahapatra et al., 2009 [20].
The reaction mixture considered consisted of 50mM Tris
(hydroxymethyl) amino methane (pH 8.2), 1mM diethylen-
etriamine penta acetic acid, and 20–50μLo fs a m p l e .T h e
reaction was initiated by addition of 0.2mM pyrogallol and
the absorbance measured kinetically at 420nm at 25◦Cf o r
3min. SOD activity was expressed as unit/mg protein.
2.10.8. Determination of Catalase (CAT) Activity. Catalase
activity of spleen homogenate was measured by the method
of KarMahapatra et al., 2009 [20]. The ﬁnal reaction volume4 Pathology Research International
of 3mL contained 0.05M Tris-buﬀer, 5mM EDTA (pH 7.0),
and 10mM H2O2 (in 0.1M potassium phosphate buﬀer, pH
7.0). About 50μL of sample was added to the above mixture.
T h er a t eo fc h a n g eo fa b s o r b a n c ep e rm i na t2 4 0 n mw a s
recorded. Catalase activity was calculated by using the molar
extinction coeﬃcient of 43.6M−1 cm−1 for H2O2. The level
of CAT was expressed as unit/mg protein.
2.10.9. Determination of Glutathione Peroxidase (GPx) Activ-
ity. The GPx activity of spleen homogenate was measured by
the method of KarMahapatra et al., 2009 [20]. The reaction
mixture contained 50mM potassium phosphate buﬀer (pH
7.0), 1mM EDTA, 1mM sodium azide, 0.2mM NADPH,
1U glutathione reductase, and 1mM reduced glutathione.
The sample, after its addition, was allowed to equilibrate
for 5min at 25◦C. The reaction was initiated by adding
0.1mLof2.5mMH2O2.Absorbanceat340nmwasrecorded
for 5min. Values were expressed as nmol of NADPH
oxidized to NADP by using the extinction coeﬃcient of
6.2×103 M−1 cm−1 at 340nm. The activity of GPx was
expressed in terms of nmol NADPH consumed/min/mg
protein.
2.10.10. Determination of Glutathione Reductase (GR) Activ-
ity. The GR activity spleen homogenate was measured by
the method of KarMahapatra et al., 2009 [20]. The tubes for
enzyme assay were incubated at 37◦C and contained 2.0mL
o f9m MG S S G ,0 . 0 2m Lo f1 2m MN A D P H ,N a 4 ,2 . 6 8m L
of 1/15M phosphate buﬀer (pH 6.6), and 0.1mL of sample.
The activity of this enzyme was determined by monitoring
the decrease in absorbance at 340nm. The activity of GR
was expressed in terms of nmol NADPH consumed/min/mg
protein.
2.10.11. Determination of Glutathione-S-Transferase (GST)
Activity. The GST activity of spleen homogenate was mea-
sured by the method of KarMahapatra et al., 2009 [20].
The tubes of enzyme assay were incubated at 25◦Ca n d
contained 2.85mL of 0.1M potassium phosphate (pH 6.5)
containing 1mM of GSH, 0.05mL of 60mM 1-chloro-2,
4-dinitrobengene and 0.1mL of sample. The activity of
this enzyme was determined by monitoring the increase in
absorbance at 340nm. The activity of GST was expressed in
terms of nmol NADPH consumed/min/mg protein.
2.10.12. DNA Fragmentation Assay by Diphenylamine (DPA)
Assay. The diphenylamine (DPA) reaction of spleen was
performed by the method of Perandones et al., 1993 [21].
Perchloric acid (0.5M) was added to the sample containing
uncutDNA(resuspendedin200μLofhypotoniclysisbuﬀer)
and to the other half of the supernatant containing DNA
fragments. Then two volumes of a solution consisting of
0.088M DPA, 98% (v/v) glacial acetic acid, 1.5% (v/v)
sulphuric acid, and a 0.5% (v/v) concentration of 1.6%
acetaldehyde solution were added. The samples were stored
at 4◦C for 48h. The reaction was quantiﬁed spectrophoto-
metrically at 575nm. The percentage of fragmentation was
calculatedastheratioofDNAinthesupernatantstothetotal
DNA.
2.10.13. Protein Estimation. Protein was determined using
bovine serum albumin as standard according to Lowry et al.,
1951 [22].
2.11. Statistical Analysis. T h ed a t aw e r ee x p r e s s e da sm e a n
± SEM, n = 6. Comparisons between the means of control
andVRSA-treatedgroupweremadebytwo-wayANOVAtest
(using a statistical package, Origin 6.1, Northampton, Mass,
USA) with multiple comparison t-tests, P<0.05 as a limit of
signiﬁcance.
3. Results
3.1. Characterization of CMC-EDBE-FA. The peak assign-
ment of CMC was as follows: 1741cm−1 (–COOH), 1070–
1136cm−1 (–C–O) and 1624 and 1506cm−1 (–NH+
3). FA-
EDBE showed the characteristic absorption bands at 1650
and 1550cm−1 located in the zone related to the (–CONH–),
corresponding, respectively, to the (C=O) stretching band
and to the (–NH) bending vibration band. The presence
of these two bands indicates that an amide bond has
been formed between –COOH of folic acid and the –NH2
amine end group of EDBE. More characteristics of these
two bands have become more prominent and intense in
CMC-EDBE-FA. This provides evidence for the formation
of an extra amide bond during the attachment of folic
acid. 1H NMR spectrum of CMC-EDBE-FA showed the
peaks at about 1.9ppm attributed to the methyl hydrogen
of acetamido-2-deoxy-β-D-glucopyranosyl unit; the peaks
at about 2.9–3.2ppm attributed to methylene hydrogen
atoms of EDBE and 3.5–4ppm observed the glucopyranosyl
hydrogen atoms. It was clear that the proton peaks of 8.7,
7.6, 6.9, and 6.4ppm were observed in 1HN M Rs p e c t r u m
of CMC-EDBE-FA. No such peaks were observed in the
same chemical shifts of 1H NMR spectrum for CMC.
The appearance of these peaks conﬁrms the successful
conjugation of FA-EDBE with CMC. The size of CMC-
EDBE-FA self-assembled nanoparticles in aqueous medium
measured by dynamic laser light scattering (DLS) ranged
from 210 ± 40nm. The morphology of CMC-EDBE-FA
self-aggregated nanoparticles was investigated by TEM. The
nanoaggregateshowsasphericalgeometryandhasauniform
size. At lower magniﬁcation nanoparticles having an average
size of about 50nm were observed (ﬁgures are not shown)
[14].
3.2. Histopathological Study. Histopathological analysis re-
vealed that VRSA infection resulted in severe pathological
changes and tissue injury in spleen. On the other hand,
treatment of nanoconjugated vancomycin showed recov-
ery of tissue damage in spleen. This was conﬁrmed by
histopathological examinations of the spleen. Microscopic
observations of control spleen showed regular structure
of red pulp and white pulp (Figure 1(a)) while in VRSA-
infected group the spleen showed degeneration of red pulp
and white pulp (Figure 1(b)). Treatment of nanoconjugated
vancomycininVRSA-infectiongroupcausedregenerationof
r e dp u l p( Figure 1(c)).Pathology Research International 5
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Figure 1: Photomicrographs of the histopathological analysis of the mice spleen tissues (400x). (a) Control group: normal red pulp
(arrow) and white pulp (black diamond); (b) VRSA-infected group: degeneration of red pulp (arrow) and white pulp (black diamond);
(c) nanoconjugated-vancomycin-treated group: red pulp (arrow) and white pulp (black diamond).
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Figure 2: Viable bacteria count in blood of control, VRSA-
infected, and nanoconjugated-vancomycin-treated group. Values
are expressed as mean ± SEM, n = 6. ∗indicates signiﬁcant
diﬀerence (P<0.05) compared to control group. #indicates
signiﬁcant diﬀerence (P<0.05) compared to VRSA-infected group.
3.3. Viable Bacteria Count in Blood. From our study it was
observed that viable bacterial count in blood was increased
signiﬁcantly in VRSA-infected group which was eliminated
after treatment with nanoconjugated vancomycin (Figure 2).
3.4. Nitrite (NO) Level and Myeloperoxidase (MPO) Activity.
Nitrate (NO) is an indicator of free radical generation.
Myeloperoxidase (MPO) is an important enzyme to produce
hypochlorous acid (HOCl) in cellular system that leads
to oxidative damage. NO level and MPO activity were
signiﬁcantly (P<0.05) increased in spleen by 195.49% and
190.94%, respectively, due to VRSA infection as compared
to control group, in which they were signiﬁcantly (P<0.05)
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Figure 3: Nitrate (NO) generation and myeloperoxidse (MPO)
in spleen of control, VRSA-infected, and nanoconjugated-
vancomycin-treated group. Values are expressed as mean ± SEM,
n = 6. ∗indicates signiﬁcant diﬀerence (P<0.05) compared to
controlgroup. #indicatessigniﬁcantdiﬀerence(P<0.05)compared
to VRSA-infected group.
decreased by 37.03% and 44.76% due to treatment of
nanoconjugated vancomycin (Figure 3).
3.5. Lipid Peroxidation (MDA) and Protein Oxidation (PC)
Level. Lipid peroxidation and protein oxidation are two
important determinants to access the cellular damage. Lipid
peroxidation in terms of malondialdehyde level and protein
oxidationintermsofproteincarbonyllevelweresigniﬁcantly
(P<0.05) increased in spleen of VRSA-infected group by
399.90% and 172.36%, respectively, as compared to control
group, in which they were signiﬁcantly (P<0.05) decreased
by 65.28% and 69.54% due to treatment of nanoconjugated
vancomycin (Figure 4).6 Pathology Research International
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Figure 4: Lipid peroxidation (MDA) level and protein carbonyl
(PC) contents in spleen of control, VRSA-infected, and nano-
conjugated-vancomycin-treated group. Values are expressed as
mean ± SEM, n = 6. ∗indicates signiﬁcant diﬀerence (P<0.05)
compared to control group. #indicates signiﬁcant diﬀerence (P<
0.05) compared to VRSA-infected group.
3.6. Reduced Glutathione (GSH) and Oxidized Glutathione
(GSSG). Glutathione is an important antioxidant in cel-
lular system. So, to understand glutathione level, we have
measured both reduced and oxidized form of glutathione.
The reduced glutathione level was decreased signiﬁcantly
(P<0.05) by 64.46% in spleen of VRSA-infected group, as
compared to control, whereas the oxidized glutathione level
was increased signiﬁcantly (P<0.05) by 88.94%, as com-
pared to control. Treatment of nanoconjugated vancomycin
signiﬁcantly (P<0.05) increased GSH level by 130.65% and
decreased GSSG level signiﬁcantly (P<0.05) by 33.28% in
spleen (Figure 5).
3.7. Superoxide Dismutase (SOD) and Catalase (CAT) Activ-
ity. The super oxide dismutase (SOD) and catalase (CAT)
activities were measured to understand the antioxidant
enzymes status in spleen of VRSA-infected group. SOD
and CAT activities were decreased signiﬁcantly (P<0.05)
by 63.31% and 56.95% in spleen of VRSA-infected group,
respectively, as compared to control, in which they were
signiﬁcantly (P<0.05) increased by 133.78% and 95.62%
due to treatment of nanoconjugated vancomycin (Figure 6).
3.8. Glutathione Peroxidase (GPx), Glutathione Reductase
(GR), and Glutathione-S-Transferase (GST) Activity. Glu-
tathione peroxidase (GPx), glutathione reductase (GR), and
glutathione-s-transferase (GST) were measured to under-
stand the antioxidant enzymes status in spleen of VRSA-
infected group. GPx, GR, and GST activities were decreased
signiﬁcantly (P<0.05) by 70.12%, 47.28%, and 53.68%
in spleen of VRSA-infected group, respectively, as compared
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Figure 5: Reduced glutathione (GSH) and oxidized glutathione
(GSSG) level in spleen of control, VRSA-infected, and nano-
conjugated-vancomycin-treated group. Values are expressed as
mean ± SEM, n = 6. ∗indicates signiﬁcant diﬀerence (P<0.05)
compared to control group. #indicates signiﬁcant diﬀerence (P<
0.05) compared to VRSA-infected group.
to control, in which they were signiﬁcantly (P<0.05)
increased by 184.08%, 114.4%, and 98.26% due to treatment
of nanoconjugated vancomycin (Figure 7).
3.9. DNA Fragmentation. DNA fragmentation was signif-
icantly (P<0.05) increased in spleen by 391.43% as
compared to control in which it was signiﬁcantly (P<0.05)
decreased by 61.01% due to treatment of nanoconjugated
vancomycin (Figure 8).
4. Discussion
Staphylococcal infections caused by VRSA are increasing
and their reduced therapeutic responsiveness to vancomycin
represents an emerging threat to public health. Infection is a
majorcomplicationofimplanteddevices.Patientsfrequently
do not respond to high doses of antimicrobial agents even
if administered for prolonged periods, and foreign bodies
usually must be removed to achieve cure. It is known that
susceptibility to antibiotics may be profoundly aﬀected by
growth of microorganisms near biomaterials. In vivo models
are characterized by an artiﬁcial environment in which
bacteria grow for a short time in the absence of host factors
under selected, not necessarily physiologic, conditions.
Theresultsofthepresentstudydemonstratedthatinvivo
infection of VRSA causes alteration of oxidant-antioxidant
status in spleen, as evidenced by enhanced NO, MPO, MDA,
PC, and GSSG level and decreased GSH level and also SOD,
CAT, GPx, GR, and GST activity.
CMC-EDBE-FA nanoparticles were prepared by the
carboxylic group (–COOH) of folic acid and –COOH
group of functionalized carboxymethyl chitosan connectedPathology Research International 7
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Figure 6: Superoxide dismutase (SOD) and catalase (CAT) activ-
ity in spleen of control, VRSA-infected, and nanoconjugated-
vancomycin-treated group. Values are expressed as mean ± SEM,
n = 6. ∗indicates signiﬁcant diﬀerence (P<0.05) compared to
controlgroup. #indicatessigniﬁcantdiﬀerence(P<0.05)compared
to VRSA-infected group.
through the end-amino groups hydrophilic spacer, 2,2 -
(ethylenedioxy)bis(ethylamine). It is well known that car-
boxymethyl chitosan is easily soluble in water but folic acid
is much less soluble in water. When carboxymethyl chitosan
is connected by folic acid through a spacer, carboxymethyl
chitosan may act as a hydrophilic part and folic acid as a
hydrophobic part.
The results of our study demonstrates that nanocon-
jugated vancomycin eliminates the bacterial infection and
recovers the spleen from infection (Figures 1 and 2),
indicating its beneﬁcial role against VRSA infection. It is
evident from our study that VRSA infection in mice is
associated with enhanced nitrate generation, MPO activity,
MDAlevel,PClevel,andGSSGlevelanddecreasedGSHlevel
and as well as decreased enzymatic antioxidant (SOD, CAT,
GPx, GR, and GST) activity in spleen, which are ameliorated
by treatment of nanoconjugated vancomycin (Figures 3–7).
Moreover DNA damage assessed by DPA assay due to VRSA
infection was also observed in spleen, which is protected by
treatment of nanoconjugated vancomycin (Figure 8).
In this study, signiﬁcant elevation of nitrate level and
MPO activity in spleen was observed in VRSA-infected
mice,whichweredecreasedinnanoconjugated-vancomycin-
treated group. Treatment of nanoconjugated vancomycin to
VRSA-infected mice decreased NO level and MPO activity
signiﬁcantly in spleen (Figure 3). Nitric oxide (NO) is a free
radical synthesized by nitric oxide synthase (NOS). NOS
is composed of two identical monomers with molecular
weights ranging from 130 to 160kDa [23]. Our previous
study showed that nitric oxide synthesis in lymphocytes as
well as its release in serum is high during VSSA and VRSA
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Figure 7: Glutathione peroxidase (GPx), glutathione reductase
(GR), and glutathione-s-transferase (GST) activity in spleen of
control, VRSA-infected, and nanoconjugated-vancomycin-treated
group. Values are expressed as mean ± SEM, n = 6. ∗indicates
signiﬁcant diﬀerence (P<0.05) compared to control group.
#indicates signiﬁcant diﬀerence (P<0.05) compared to VRSA-
infected group.
infection, which can be related to an alteration in oxidant-
antioxidant potential [16]. Thus, higher level of nitrite by
VRSA infection may be due to high production of free rad-
icals. Nanoconjugated vancomycin plays the role of antiox-
idant to prevent the nitrate generation maybe through the
inhibition of inducible nitric oxide synthase (iNOS) expres-
sion [24]. Hypochlorous acid (HOCl) is generated in the
presence of myeloperoxidase and initiates the deactivation of
antiproteases and the activation of latent proteases and leads
to the cellular damage [25]. In this study, nanoconjugated
vancomycin inhibited the myeloperoxidase activity which
was increased due to VRSA infection, suggesting a protective
role of nanoconjugated vancomycin (Figure 3). These results
suggest that the cellular antioxidants level either was reached
in a higher concentration to exert antioxidant eﬀects or
scavenged the free radical produced by the myeloperox-
idase [26]. Thus, in addition to the antioxidant system,
nanoconjugated vancomycin may indirectly protect spleen
from VRSA-infection-induced oxidative damage. Thus, free
radical depletion by the antioxidant agents seems to be
beneﬁcial for preventing the damage of lipid and protein.
In this study, signiﬁcant elevation of malondialdehyde
(MDA) and protein carbonyl level was observed in spleen of
VRSA-infected mice, whereas treatment of nanoconjugated
vancomycin in VRSA-infected mice decreased lipid perox-
idation and protein oxidation signiﬁcantly in lymphocytes
(Figure 4). It may be due to the generation of free radicals
(mainly NO) which may react with protein in addition
to lipids. Lipid peroxidation is known to disturb the
integrity of cellular membranes, leading to the leakage of8 Pathology Research International
0
5
10
15
20
25
30
35
40
45
50
55
60
65
#
∗
D
N
A
f
r
a
g
m
e
n
t
a
t
i
o
n
(
%
)
Control
VRSA infected
NV treated
Figure 8: Quantitative estimation of DNA fragmentation assay
by diphenylamine (DPA) assay in spleen of control, VRSA-
infected, and nanoconjugated-vancomycin-treated group. Values
are expressed as mean ± SEM, n = 6. ∗indicates signiﬁcant
diﬀerence (P<0.05) compared to control group. #indicates
signiﬁcant diﬀerence (P<0.05) compared to VRSA-infected group.
cytoplasmic enzymes [27]. Protein carbonyls formation has
been indicated to be an earlier marker of protein oxidation.
Oxidationofproteinmaybeduetoeitherexcessiveoxidation
of proteins or decreased capacity to clean up oxidative
damaged proteins. Oxidative modiﬁcation of proteins may
lead to the structural alteration and functional inactivation
of many enzyme proteins [28], as evidenced by the decreased
activityofdiﬀerentantioxidantenzymeslikeSOD,CAT,GPx,
GR, and GST.
Imbalance between the generation of reactive oxygen
species (ROS) and the antioxidant system causes oxida-
tive stress. Glutathione, an important cellular reductant,
is involved in protection against free radicals, peroxides
and toxic compounds in cellular systems [29]. In the
present study, the reduced glutathione level was signiﬁcantly
decreased in spleen of VRSA-infected mice, whereas treat-
ment of nanoconjugated vancomycin in VRSA-infected mice
increased the GSH level (Figure 5). In this study, it was
observed that oxidized glutathione level was increased in
spleen of VRSA-infected mice, which was ameliorated due
to nanoconjugated vancomycin treatment (Figure 5). The
decreased GSH levels represent its increased utilization due
to VSSA and VRSA infection. On the other hand, decreasing
GSH level may be due to increasing level of lipid oxidation
products which may be associated with less availability of
NADPH required for the activity of glutathione reductase
(GR) to transform GSSG to GSH due to the increasing
production of ROS in form of NO [30]. In our present
study, the increasing levels of GSSG and decreasing GR
activity (Figure 7) due to VRSA infection may support the
explanation.
Antioxidant enzymes are considered to be a primary
defensethatpreventsbiologicalmacromoleculesfromoxida-
tive damage. SOD rapidly dismutates superoxide anion
(O2
.−)t ol e s sd a n g e r o u sH 2O2, which is further degraded
by CAT and GPx to water and oxygen [31]. The results of
the present study showed a signiﬁcant fall in SOD and CAT
activities in spleen of VRSA-infected group, whereas treat-
ment of nanoconjugated vancomycin in VRSA-infected mice
signiﬁcantly increased the SOD and CAT activity (Figure 6).
SOD, dismutates O2
.− and the same in turn is a potent
inhibitor of CAT [32]. The depletion in SOD activity was
maybe due to disposing oﬀ the free radicals, produced due
to VSSA and VRSA infection. Beside this, during infection,
H2O2 produced by dismutation of superoxide anion may
havebeen eﬃciently converted to O2 by CAT and the enzyme
activities showed a marked reduction. The depletion of
antioxidantenzymeactivitywasmaybeduetoinactivationof
the enzyme proteins by VSSA and VRSA-infection-induced
NO generation, depletion of the enzyme substrates, and/or
downregulation of transcription and translation processes.
GPx works nonspeciﬁcally to scavenge and decompose
excess hydroperoxides including H2O2, which may be preva-
lent under oxidative stress [33]. Glutathione-s-transferase
(GST) mainly detoxiﬁes electrophilic compounds [34]a n d
has a well-established role in protecting cells from mutagens
and carcinogens as a free radical scavenger along with
glutathione. In the present study, the signiﬁcant decreasing
of GSH level and GSH-dependent enzymes, that is, GPx,
GR, and GST (Figure 7), in VRSA infection may be due to
increased utilization to scavenge the free radical generation.
The results of the present study showed a signiﬁcant fall
of GPx, GR, and GST activities in spleen of VRSA-infected
group, whereas treatment of nanoconjugated vancomycin
in VRSA-infected mice signiﬁcantly increased the GPx,
GR, and GST activity in spleen (Figure 7). In the present
study, it was observed that MDA level (Figure 4) and DNA
fragmentation(Figure 8)weresigniﬁcantlyelevatedinspleen
due to VRSA infection. This elevated MDA level decreases
GSH level (Figure 5) and SOD activity (Figure 6), which
may be associated with DNA fragmentation. In this study,
it was observed that DNA fragmentation increased in VRSA-
infected spleen, which was brought back near to control due
to nanoconjugated vancomycin treatment.
In conclusion, the study showed here that, spleen is sus-
ceptibletoVRSAinfectionthroughtheincreasedproduction
of nitric oxide which leads to decreased antioxidant status in
spleen and nanoconjugated vancomycin protects the spleen
from such infection by decreasing free radical generation,
lipid, and protein damage, and also by increasing the
antioxidant status. Hence, the nanoconjugated vancomycin
can be used as a potent free radical scavenger antioxidative
product and can be used as a potential therapeutic agent
against staphylococcal infection.
Abbreviations
CAT: Catalase
CFU: Colony formation unit
CMC: Carboxymethyl chitosanPathology Research International 9
CMC-EDBE-FA: Carboxymethyl chitosan-2,2 -
(ethylenedioxy)bis(ethylamine)-
folate
CS: Chitosan
DNA: Deoxyribonucleic acid
DPA: Diphenylamine
DPX: Dibutyl phthalate xylol
DTNB: 5 ,5 -dithio(bis)-2-nitrobenzoic acid
EDTA: Ethylene diamine tetra acetate
GPx: Glutathione peroxidase
GR: Glutathione reductase
GSSG: Oxidized glutathione
GSH: Reduced glutathione
GST: Glutathione-s-transferase
H2O2:H y d r o g e n p e r o x i d e
MDA: Malondialdehyde
MPO: Myeloperoxidase
MRSA: Methicillin-resistant Staphylococcus
aureus
NADPH: Nicotinamide adenine dinucleotide
phosphate
NO: Nitric oxide
PC: Protein carbonyls
ROS: Reactive oxygen species
SDS: Sodium dodecyl sulfate
SOD: Superoxide dismutase
SSA: Sulfosalicylic acid
TBA: Thiobutiric acid
TBARS: Thiobutiric acid reactive substance
TCA: Trichloroacetic acid
VRSA: Vancomycin-resistant Staphylococcus
aureus.
Conﬂict of Interests
The authors declare that there is no conﬂict of interests.
Acknowledgments
The authors express gratefulness to the Department of
Biotechnology, Government of India for funding. The
authors also express gratefulness to the Indian Institute of
Technology, Kharagpur and Vidyasagar University, Midna-
pore for providing the facilities to execute this study.
References
[1] J. Kluytmans, A. Van Belkum, and H. Verbrugh, “Nasal
carriage of Staphylococcus aureus: epidemiology, underlying
mechanisms, and associated risks,” Clinical Microbiology
Reviews, vol. 10, no. 3, pp. 505–520, 1997.
[2] W. M. M. Kirby, “Extraction of a highly potent penicillin
inactivator from penicillin resistant staphylococci,” Science,
vol. 99, no. 2579, pp. 452–453, 1944.
[3] H. C. Neu, “The crisis in antibiotic resistance,” Science, vol.
257, no. 5073, pp. 1064–1073, 1992.
[4] D. M. Livermore, “Antibiotic resistance in staphylococci,”
International Journal of Antimicrobial Agents,v o l .1 6 ,n o .1 ,p p .
S3–S10, 2000.
[ 5 ]O .H .L o w r y ,N .J .R o s e n b r o u g h ,A .L .F a r r ,a n dR .J .R a n d a l l ,
“Protein measurement with the Folin phenol reagent,” The
Journal of biological chemistry, vol. 193, no. 1, pp. 265–275,
1951.
[ 6 ]D .M .S i e v e r t ,M .L .B o u l t o n ,G .S t o l t m a n ,D .J o h n s o n ,M .G .
Stobierski, and F. P. Downes, “Staphylococcus aureus resistant
tovancomycin—UnitedStates,2002,”MorbidityandMortality
Weekly Report, vol. 51, pp. 565–567, 2002.
[7] S.P .Chakraborty ,S.K arM ahapatra,M.Bal,andS.R o y ,“I sola-
tion and identiﬁcation of vancomycin resistant Staphylococcus
aureus from post operative pus sample,” Alameen Journal of
Medical Sciences, vol. 4, no. 2, pp. 52–68, 2011.
[8] E.Brouillette,G.Grondin,L.Shkreta,P.Lacasse,andB.G.Tal-
bot, “In vivo and in vitro demonstration that Staphylococcus
aureus is an intracellular pathogen in the presence or absence
of ﬁbronectin-binding proteins,” Microbial Pathogenesis, vol.
35, no. 4, pp. 159–168, 2003.
[9] T. Steigbigel, L. H. Lambert, and J. S. Remington, “Phagocytic
and bactericidal properties of normal human monocytes,”
Journal of Clinical Investigation, vol. 53, no. 1, pp. 131–142,
1974.
[10] A. Dryla, D. Gelbmann, V. A. Gabain, and E. Nagy, “Identi-
ﬁcation of a noveliron regulated Staphylococcal surface pro-
tein with haptogloinhemoglobinbinding activity,” Molecular
Microbiology, vol. 49, pp. 37–53, 2003.
[11] E. Khor and L. Y. Lim, “Implantable applications of chitin and
chitosan,” Biomaterials, vol. 24, no. 13, pp. 2339–2349, 2003.
[12] S. S. Koide, “Chitin-chitosan: properties, beneﬁts and risks,”
Nutrition Research, vol. 18, no. 6, pp. 1091–1101, 1998.
[13] X. F. Liu, Y. L. Guan, D. Z. Yang, Z. Li, and K. D.
Yao, “Antibacterial action of chitosan and carboxymethylated
chitosan,” Journal of Applied Polymer Science, vol. 79, no. 7, pp.
1324–1335, 2001.
[14] S. P. Chakraborty, S. K. Sahu, S. K. KarMahapatra et al.,
“Nanoconjugated vancomycin: new opportunities for the
development of anti-VRSA agents,” Nanotechnology, vol. 21,
no. 10, Article ID 105103, 2010.
[15] S. P. Chakraborty, S. K. KarMahapatra, S. K. Sahu, P.
Pramanik, and S. Roy, “Antioxidative eﬀect of folate-modiﬁed
chitosan nanoparticles,” Asian Paciﬁc Journal of Tropical
Biomedicine, vol. 1, no. 1, pp. 29–38, 2011.
[16] S. P. Chakraborty, S. K. KarMahapatra, S. K. Sahu, S. Chat-
topadhyay, P. Pramanik, and S. Roy, “Nitric oxide mediated
Staphylococcus aureus pathogenesis and protective role of
nanoconjugated vancomycin,” Asian Paciﬁc Journal of Tropical
Biomedicine, vol. 1, no. 2, pp. 105–112, 2011.
[ 1 7 ]D .G .H a t t i e ,H .L .J o n ,E .C .T o n y ,S .W .B r i d g e t ,L .C .
Ambrose, and P. L. Frederik, “Survival of Staphylococcus
aureus inside neutrophils contributes to infection,” Journal of
Immunology, vol. 164, no. 7, pp. 3713–3722, 2000.
[18] K. Chandran and P. M. Venugopal, “Modulatory eﬀects of
curcumin on lipid peroxidation and antioxidant status during
nicotine-inducedtoxicity,”PolishJournalofPharmacology,vol.
56, no. 5, pp. 581–586, 2004.
[19] B. O. Iranloye and A. F. Bolarinwa, “Eﬀect of nicotine
administration on weight and histology of some vital visceral
organs in female albino rats,” Nigerian Journal of Physiological
Sciences, vol. 24, no. 1, pp. 7–12, 2009.
[20] S. K. KerMahapatra, S. P. Chakraborty, S. Das, and S. Roy,
“Methanol extract of Ocimum gratissimum protects murine
peritoneal macrophages from nicotine toxicity by decreas-
ing free radical generation, lipid and protein damage and
enhances antioxidant protection,” Oxidative Medicine and
Cellular Longevity, vol. 2, no. 4, pp. 222–230, 2009.10 Pathology Research International
[21] C. E. Perandones, V. A. Illera, D. Peckham, L. L. Stunz, and
R. F. Ashman, “Regulation of apoptosis in vitro in mature
murine spleen T cells,” Journal of Immunology, vol. 151, no.
7, pp. 3521–3529, 1993.
[ 2 2 ]O .H .L o w r y ,N .J .R o s e b r o u g h ,A .L .F a r r ,a n dR .J .R a n d a l l ,
“Protein measurement with the Folin phenol reagent,” The
Journal of biological chemistry, vol. 193, no. 1, pp. 265–275,
1951.
[23] N.P.LeeandC.Y.Cheng,“Nitricoxideandcyclicnucleotides:
theirrolesinjunctiondynamics andspermatogenesis,” Oxida-
tive medicine and cellular longevity, vol. 1, no. 1, pp. 25–32,
2008.
[24] W. Li, R. Tsubouchi, S. Qiao, M. Haneda, K. Murakami, and
M. Yoshino, “Inhibitory action of eugenol compounds on
the production of nitric oxide in RAW 264.7 macrophages,”
Biomedical Research, vol. 27, no. 2, pp. 69–74, 2006.
[25] G. W. Sullivan, I. J. Sarembock, and J. Linden, “The role
of inﬂammation in vascular diseases,” Journal of Leukocyte
Biology, vol. 67, no. 5, pp. 591–602, 2000.
[26] M. Ogata, M. Hoshi, S. Urano, and T. Endo, “Antioxidant
activity of eugenol and related monomeric and dimeric
compounds,” Chemical and Pharmaceutical Bulletin, vol. 48,
no. 10, pp. 1467–1469, 2000.
[27] M. Bagchi, D. Bagchi, E. Adickes, and S. J. Stohs, “Chronic
eﬀects of smokeless tobacco extract on rat liver histopathology
and production of HSP-90,” Journal of Environmental Pathol-
ogy, Toxicology and Oncology, vol. 14, no. 2, pp. 61–68, 1995.
[28] A. Z. Reznick and L. Packer, “Oxidative damage to proteins:
spectrophotometric method for carbonyl assay,” Methods in
Enzymology, vol. 233, pp. 357–363, 1994.
[29] H. Gerster, “β-carotene, vitamin E and vitamin C in diﬀerent
stages of experimental carcinogenesis,” European Journal of
Clinical Nutrition, vol. 49, no. 3, pp. 155–168, 1995.
[30] S. Sarkar, P. Yadav, R. Trivedi, A. K. Bansal, and D. Bhatnagar,
“Cadmium-induced lipid peroxidation and the status of the
antioxidant system in rat tissues,” Journal of Trace Elements in
Medicine and Biology, vol. 9, no. 3, pp. 144–149, 1995.
[31] G. J. Wetscher, M. Bagchi, D. Bagchi et al., “Free radical
production in nicotine treated pancreatic tissue,” Free Radical
Biology and Medicine, vol. 18, no. 5, pp. 877–882, 1995.
[32] L. Ashakumari and P. L. Vijayammal, “Addictive eﬀect of
alcohol and nicotine on lipid peroxidation and antioxidant
defense mechanism in rats,” Journal of Applied Toxicology, vol.
16, pp. 305–308, 1996.
[33] S. M. Somani, “Exercise, drugs and tissue speciﬁc antioxidant
system,” in Pharmacology in Exercise and Sports,S .M .S o m a n i ,
Ed., pp. 57–95, CRC Press, Boca Raton, Fla, USA, 1996.
[34] T. Hemachand, B. Gopalakrishnan, D. M. Salunke, S. M.
Totey, and C. Shaha, “Sperm plasma-membrane-associated
glutathione S-transferases as gamete recognition molecules,”
Journal of Cell Science, vol. 115, no. 10, pp. 2053–2065, 2002.